Avidity Biosciences Cash from Investing (TTM) Insights

Avidity Biosciences Inc (RNA)

25.96 -1.17 (-4.31%) USD | NASDAQ | May 10, 16:00

25.96 0.00 (0.00%) After-Hours: 19:06

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-130.07M
September 30, 2023	-188.88M
June 30, 2023	-146.47M
March 31, 2023	-210.16M
December 31, 2022	-189.96M
September 30, 2022	-266.25M
June 30, 2022	-277.98M
March 31, 2022	-257.47M
December 31, 2021	-82.52M

Date	Value
September 30, 2021	-5.383M
June 30, 2021	-5.428M
March 31, 2021	-8.30M
December 31, 2020	-7.785M
September 30, 2020	-0.946M
June 30, 2020	-0.115M
March 31, 2020	-0.245M
December 31, 2019	-0.235M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-277.98M

Minimum

Jun 2022

-0.115M

Maximum

Jun 2020

-104.60M

Average

-82.52M

Median

Dec 2021

Cash from Investing (TTM) Benchmarks